(Q37439553)

20 August 2017

1 reference

title

Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? (English)

1 reference

20 August 2017

2

1 reference

20 August 2017

3

Roberto Chiarle

1 reference

20 August 2017

5

Giorgio Inghirami

1 reference

20 August 2017

4

Domenico Novero

1 reference

20 August 2017

Alessandro Fornari

1

1 reference

20 August 2017

publication date

1 December 2009

1 reference

20 August 2017

published in

Hematological Oncology

1 reference

20 August 2017

volume

27

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

161-170

1 reference

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

20 August 2017

cites work

1 reference

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

21 January 2018

1 reference

Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity

21 January 2018

1 reference

ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

21 January 2018

1 reference

Peripheral T-cell lymphomas

21 January 2018

1 reference

7 January 2021

Updated Kiel classification for lymphomas

1 reference

7 January 2021

CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.

1 reference

7 January 2021

A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').

1 reference

7 January 2021

Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35)

1 reference

7 January 2021

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

7 January 2021

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

1 reference

7 January 2021

Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance

1 reference

7 January 2021

ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified

1 reference

7 January 2021

Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology

1 reference

7 January 2021

A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma

1 reference

7 January 2021

Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes).

1 reference

7 January 2021

Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases

1 reference

7 January 2021

Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma

1 reference

7 January 2021

World Health Organization Classification of lymphomas: a work in progress

1 reference

7 January 2021

Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma

1 reference

7 January 2021

The anaplastic lymphoma kinase in the pathogenesis of cancer

1 reference

7 January 2021

Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein.

1 reference

7 January 2021

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

1 reference

7 January 2021

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

1 reference

7 January 2021

Characterization of the expression of the ALK receptor tyrosine kinase in mice

1 reference

7 January 2021

Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway

1 reference

7 January 2021

A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells

1 reference

7 January 2021

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

1 reference

7 January 2021

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types

1 reference

7 January 2021

Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation

1 reference

7 January 2021

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

1 reference

7 January 2021

Overexpression of NPM–ALK induces different types of malignant lymphomas in IL-9 transgenic mice

1 reference

7 January 2021

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

1 reference

7 January 2021

Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines.

1 reference

7 January 2021

Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma

1 reference

7 January 2021

Anaplastic lymphoma kinase proteins in growth control and cancer

1 reference

7 January 2021

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

1 reference

7 January 2021

The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration

1 reference

7 January 2021

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

1 reference

7 January 2021

Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo

1 reference

7 January 2021

Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

1 reference

7 January 2021

Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma

1 reference

7 January 2021

NPM/ALK downregulates p27Kip1 in a PI-3K-dependent manner.

1 reference

7 January 2021

NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.

1 reference

7 January 2021

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes

1 reference

7 January 2021

Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas

1 reference

7 January 2021

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

1 reference

7 January 2021

Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.897

1 reference

20 August 2017

1 reference